07.09.10

Haupt Pharma at the ICSE - Contract manufacturing and development at the highest level confirmed by successful completion of an FDA audit

06.09.10

Flexible and fast blister line for packaging cytostatics and immunosuppressives

27.08.10

Hans-Christian Semmler has resigned from his position as Chief Executive Officer of Haupt Pharma AG